Market Overview

Why Neuronetics Stock Is Trading Higher Today


Neuronetics (NASDAQ: STIM) shares are trading higher on Tuesday after BTIG reiterated a Buy rating on the stock and raised its price target from $6 to $10.

Neuronetics is a commercial-stage medical technology company. It is focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.

Neuronetics shares traded up 13.73% to $5.88 on Tuesday. The stock has a 52-week high of $9.39 and a 52-week low of $1.25.

Latest Ratings for STIM

Oct 2020Canaccord GenuityMaintainsBuy
Oct 2020BTIGReiteratesBuy
Apr 2020Canaccord GenuityMaintainsBuy

View More Analyst Ratings for STIM
View the Latest Analyst Ratings


Related Articles (STIM)

View Comments and Join the Discussion!

Posted-In: why it's movingReiteration Analyst Ratings

Latest Ratings

HYMCBMO CapitalInitiates Coverage On
DEMorgan StanleyMaintains335.0
SBNYRaymond JamesMaintains138.0
CORTHC Wainwright & Co.Maintains32.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at